Research Platform Myelofibrosis and Anemia
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis
- Status
- RECRUITING
- Phase
- NA
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Haplo-HSCT for Myelofibrosis
- Status
- RECRUITING
- Phase
- NA
A Phase 2 Study of INCB57643 (BET Inhibitor) in Combination With Ruxolitinib in JAK Inhibitor-naïve Patients With Myelofibrosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
- Status
- RECRUITING
- Phase
- N/A
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
- Status
- RECRUITING
- Phase
- N/A
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Status
- RECRUITING
- Phase
- PHASE3
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Study of GLB-001 in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- Status
- RECRUITING
- Phase
- PHASE3
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
- Status
- RECRUITING
- Phase
- N/A